HC Wainwright Reiterates Buy Rating for IceCure Medical (NASDAQ:ICCM)

IceCure Medical (NASDAQ:ICCM)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $3.00 price objective on the stock. HC Wainwright’s target price would suggest a potential upside of 308.16% from the stock’s current price.

Separately, Alliance Global Partners boosted their price objective on IceCure Medical from $1.90 to $2.90 and gave the company a “buy” rating in a research note on Wednesday, March 20th.

IceCure Medical Stock Performance

NASDAQ ICCM opened at $0.74 on Tuesday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.88 and a current ratio of 3.39. The company has a market capitalization of $33.53 million, a PE ratio of -2.23 and a beta of 0.57. IceCure Medical has a 52-week low of $0.52 and a 52-week high of $1.57. The company has a 50-day simple moving average of $0.98 and a 200 day simple moving average of $1.16.

IceCure Medical (NASDAQ:ICCM) last posted its quarterly earnings results on Tuesday, May 28th. The company reported ($0.08) EPS for the quarter, hitting analysts’ consensus estimates of ($0.08). IceCure Medical had a negative net margin of 444.30% and a negative return on equity of 101.66%. The company had revenue of $0.74 million for the quarter, compared to analysts’ expectations of $0.80 million. During the same quarter in the previous year, the firm posted ($0.08) EPS. On average, research analysts predict that IceCure Medical will post -0.28 EPS for the current year.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.